SCHEMBL6489667

SCHEMBL6489667

Cc1ccc(-c2cc(CCC(=O)O)c(=O)n(Cc3ccc(F)cc3)n2)cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HDAC3 O15379 4/20 0.48
HDAC4 P56524 4/20 0.48
HDAC1 Q13547 4/20 0.48
HDAC7 Q8WUI4 4/20 0.48
HDAC2 Q92769 4/20 0.48
HDAC10 Q969S8 4/20 0.48
HDAC11 Q96DB2 4/20 0.48
HDAC8 Q9BY41 4/20 0.48
HDAC6 Q9UBN7 4/20 0.48
HDAC9 Q9UKV0 4/20 0.48
HDAC5 Q9UQL6 4/20 0.48
NCOR2 Q9Y618 4/20 0.48
TP53 P04637 2/20 0.47
MDM2 Q00987 2/20 0.47
CNR2 P34972 9/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.43
CNR1 P21554 3/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5584307 0.87 TP53 (0.58) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL5584504 0.78 KMT2A (0.42) MEN1KMT2ATP53MDM2CNR2
SCHEMBL5584164 0.74 TP53 (0.46) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL1924540 0.73 PDE4B (0.47) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL1925297 0.73 TP53 (0.50) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL5585300 0.72 MAPT (0.46) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL1925414 0.72 MEN1 (0.47) MEN1KMT2ACNR2PTGDR2POLB
SCHEMBL1925453 0.71 PDE4B (0.47) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL5584841 0.71 PDE4B (0.47) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL27643416 0.71 TP53 (0.40) MEN1KMT2AHDAC6TP53MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6861428-B2 Water-soluble phenylpyridazine compounds and compositions containing the same KOWA CO., LTD. (JP) 2005-03-01 US disclosed
US-20040002497-A1 Water-soluble phenylpyridazine compounds and compositions containing the same KOWA CO., LTD. (JP) 2004-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002497-A1 Water-soluble phenylpyridazine compounds and compositions containing the same IL1A, IL1B, IL1R1 MEN1 4656/4885KMT2A 3413/4885HDAC3 670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.